These research studies are ongoing, but not actively recruiting subjects for participation.
This clinical trial is examining the effects of Solanezumab in patients with memory complaints, but who have not been diagnosed with MCI or AD.
Eligibility: Are between 65-85 years old with pre-clinical memory complaints
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
BAN2401 for early Dementia and Mild Cognitive Impairment
This clinical trial is examining the effects of BAN2401 in patients with MCI and very early AD.
Eligibility: MCI, AD